Puma SE (PUMG.DE)

PUMG.DE on Xetra

189.40EUR
15 Aug 2014
Price Change (% chg)

€-0.65 (-0.34%)
Prev Close
€190.05
Open
€191.50
Day's High
€192.20
Day's Low
€188.45
Volume
3,822
Avg. Vol
4,479
52-wk High
€242.50
52-wk Low
€182.95

PUMG.DE

Chart for PUMG.DE

About

Puma SE is a Germany-based company engaged in manufacture of sporting equipment, operating worldwide through its subsidiaries. The Company designs, develops and markets a range of sports and sport lifestyle articles and divides its operations into three product groups: Footwear, Apparel, and Accessories. Its footwear range... (more)

Overall

Beta: 0.42
Market Cap (Mil.): €2,910.92
Shares Outstanding (Mil.): 15.08
Dividend: 0.50
Yield (%): 0.26

Financials

  PUMG.DE Industry Sector
P/E (TTM): -- 23.64 17.80
EPS (TTM): -1.52 -- --
ROI: -0.32 16.36 16.68
ROE: -1.45 18.22 20.77
Search Stocks

UPDATE 2-Soccer-Puma buys stake to aid Dortmund's pursuit of Bayern

BERLIN, Aug 21 - Sponsors Puma, Evonik and Signal Iduna will buy a stake in Borussia Dortmund as the Ruhr Valley club raises funds to compete with Bayern Munich, the German league champions.

21 Aug 2014

Soccer club Dortmund prepares to raise capital - German paper

BERLIN, Aug 20 - German soccer club Borussia Dortmund will on Thursday announce a capital increase that could bring it around 110 million euros ($146 million) in new funds, German business daily Handelsblatt reported on Wednesday.

20 Aug 2014

UPDATE 2-Puma gets boost from World Cup, Arsenal deal

BERLIN, July 29 - German sportswear firm Puma said sales of World Cup soccer boots and national team shirts as well as new Arsenal jerseys beat its expectations as it reported second-quarter earnings that fell less than feared and reiterated its outlook.

29 Jul 2014

Puma says World Cup sales beat its expectations

BERLIN - German sportswear firm Puma said sales of World Cup soccer boots and national team shirts beat its expectations as it reported second-quarter results in line with analyst forecasts and reiterated its expectations for 2014.

29 Jul 2014

BRIEF-PUMA SE shares rise 2.7 percent in early trade after Q2 results

July 29 - Puma SE : * Shares rise 2.7 percent in early trade after Q2 results

29 Jul 2014

UPDATE 2-Refocused Puma eyes sporting chance of turnaround

* CEO says confident of 2014 turnaround (Adds CEO comment, background, detail, share price)

14 May 2014

Puma CEO not aware of takeover interest in firm

BERLIN, May 14 - The chief executive of German sportswear company Puma SE is not aware of any takeover interest in the firm, adding he has an excellent relationship with majority shareholder French luxury group Kering.

14 May 2014

Puma drug better than Herceptin in HER2 breast cancers: trial

- A mid-stage trial of Puma Biotechnology's experimental drug neratinib showed that it was more effective, given before surgery, than Herceptin, the Roche drug commonly used in women with a type of breast cancer fueled by a protein called HER2.

07 Apr 2014

Puma drug better than Herceptin in HER2 breast cancers -trial

April 7 - A mid-stage trial of Puma Biotechnology's experimental drug neratinib showed that it was more effective, given before surgery, than Herceptin, the Roche drug commonly used in women with a type of breast cancer fueled by a protein called HER2.

07 Apr 2014

Scores fall sick at Cambodian garment factories

PHNOM PENH - Scores of garment workers have fallen sick this week at factories in Cambodia, including two that produce clothing for sportswear groups Puma SE and Adidas, workers and the companies said on Thursday.

03 Apr 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics (Premium)
$25.00
Provider: Wright Reports
$472.00
Provider: MarketLine (a Datamonitor Company)
$50.00
Provider: Wright Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks